Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
2 In SURMOUNT-1, 58% of participants on tirzepatide had normal blood pressure at week 72, compared to 35% on placebo
The FDA has approved its use for chronic weight management in adults with a body mass index (BMI) of 30 or more, or a BMI of 27 or more when accompanied by at least one weight-related condition such as high blood pressure, high cholesterol, or type 2 diabetes
[PubMed ID: 27304951]
OCD can be diagnosed based on certain habits
In January, the Trump administration debuted TrumpRx.gov where consumers can purchase the medications at a discount if they are not eligible to participate in the GLP-1 bridge program
US$ 21.19
US$ 20.78
US$ 27.97
US$ 24.10
US$ 20.67
